Aphria cutting US marijuana exposure amid delisting review

Aphria is scrambling to shed direct involvement in American medical cannabis businesses as it undergoes a delisting review by its stock exchange operator. The Leamington, Ontario-based company has been in the hot seat since the TMX Group – parent of the Toronto Stock Exchange and the TSX Venture Exchange – said companies with direct business […] Aphria cutting US marijuana exposure amid delisting review is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs